|
1
|
Siegel R, Naishadham D and Jemal A: Cancer
statistics, 2013. CA Cancer J Clin. 63:11–30. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
She J, Yang P, Hong Q and Bai C: Lung
cancer in China: Challenges and interventions. Chest.
143:1117–1126. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Jemal A, Siegel R, Xu J and Ward E: Cancer
statistics, 2010. CA Cancer J Clin. 60:277–300. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Reck M: What future opportunities may
immuno-oncology provide for improving the treatment of patients
with lung cancer? Ann Oncol. 23(Suppl 8): viii28–viii34. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Krebs LT, Deftos ML, Bevan MJ and Gridley
T: The Nrarp gene encodes an ankyrin-repeat protein that is
transcriptionally regulated by the notch signaling pathway. Dev
Biol. 238:110–119. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Yun TJ and Bevan MJ: Notch-regulated
ankyrin-repeat protein inhibits Notch1 signaling: Multiple Notch1
signaling pathways involved in T cell development. J Immunol.
170:5834–5841. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kim HA, Koo BK, Cho JH, Kim YY, Seong J,
Chang HJ, Oh YM, Stange DE, Park JG, Hwang D and Kong YY: Notch1
counteracts WNT/β-catenin signaling through chromatin modification
in colorectal cancer. J Clin Invest. 122:3248–3259. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Chu BF, Qin YY, Zhang SL, Quan ZW, Zhang
MD and Bi JW: Downregulation of notch-regulated ankyrin repeat
protein exerts antitumor activities against growth of thyroid
cancer. Chin Med J (Engl). 129:1544–1552. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Imaoka T, Okutani T, Daino K, Iizuka D,
Nishimura M and Shimada Y: Overexpression of NOTCH-regulated
ankyrin repeat protein is associated with breast cancer cell
proliferation. Anticancer Res. 34:2165–2171. 2014.PubMed/NCBI
|
|
10
|
Zhu P, Wang Y, Du Y, He L, Huang G, Zhang
G, Yan X and Fan Z: C8orf4 negatively regulates self-renewal of
liver cancer stem cells via suppression of NOTCH2 signalling. Nat
Commun. 6:71222015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Goldstraw P, Crowley J, Chansky K, Giroux
DJ, Groome PA, Rami-Porta R, Postmus PE, Rusch V, Sobin L;
International Association for the Study of Lung Cancer
International Staging Committee; Participating Institutions; et al:
The IASLC lung cancer staging project: Proposals for the revision
of the TNM stage groupings in the forthcoming (seventh) edition of
the TNM Classification of malignant tumours. J Thorac Oncol.
2:706–714. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Schmittgen TD and Livak KJ: Analyzing
real-time PCR data by the comparative C(T) method. Nat Protoc.
3:1101–1108. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Geers C, Colin IM and Gerard AC:
Delta-like 4/Notch pathway is differentially regulated in benign
and malignant thyroid tissues. Thyroid. 21:1323–1330. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Guo S, Liu M and Gonzalez-Perez RR: Role
of Notch and its oncogenic signaling crosstalk in breast cancer.
Biochim Biophys Acta. 1815:197–213. 2011.PubMed/NCBI
|
|
15
|
Leong KG and Gao WQ: The Notch pathway in
prostate development and cancer. Differentiation. 76:699–716. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Rampias T, Vgenopoulou P, Avgeris M,
Polyzos A, Stravodimos K, Valavanis C, Scorilas A and Klinakis A: A
new tumor suppressor role for the Notch pathway in bladder cancer.
Nat Med. 20:1199–1205. 2014. View
Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zhang J, Wang Y, Li D and Jing S: Notch
and TGF-β/Smad3 pathways are involved in the interaction between
cancer cells and cancer-associated fibroblasts in papillary thyroid
carcinoma. Tumour Biol. 35:379–385. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Phng LK, Potente M, Leslie JD, Babbage J,
Nyqvist D, Lobov I, Ondr JK, Rao S, Lang RA, Thurston G and
Gerhardt H: Nrarp coordinates endothelial Notch and Wnt signaling
to control vessel density in angiogenesis. Dev Cell. 16:70–82.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Lamar E, Deblandre G, Wettstein D,
Gawantka V, Pollet N, Niehrs C and Kintner C: Nrarp is a novel
intracellular component of the Notch signaling pathway. Genes Dev.
15:1885–1899. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Hayward P, Kalmar T and Arias AM:
Wnt/Notch signalling and information processing during development.
Development. 135:411–424. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Brabletz T: EMT and MET in metastasis:
Where are the cancer stem cells? Cancer Cell. 22:699–701. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Preca BT, Bajdak K, Mock K, Sundararajan
V, Pfannstiel J, Maurer J, Wellner U, Hopt UT, Brummer T, Brabletz
S, et al: A self-enforcing CD44s/ZEB1 feedback loop maintains EMT
and stemness properties in cancer cells. Int J Cancer.
137:2566–2577. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Fazio C, Piazzi G, Vitaglione P, Fogliano
V, Munarini A, Prossomariti A, Milazzo M, D'Angelo L, Napolitano M,
Chieco P, et al: Inflammation increases NOTCH1 activity via MMP9
and is counteracted by Eicosapentaenoic Acid-free fatty acid in
colon cancer cells. Sci Rep. 6:206702016. View Article : Google Scholar : PubMed/NCBI
|
